Author

M. Hütter-Krönke

h-index 9 View on Semantic Scholar

We have 2 of 38 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial.

D. Kuter, W. Ghanima, Nichola Cooper et al. · The Lancet Haematology · 0 citations

Aug 2026

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

CD19 CAR T cells showed acceptable short-term tolerability in patients with treatment-refractory RA, justifying further evaluation, and the primary endpoint was met, allowing advancement to phase 2.

F. Albach, Marie C. Rehm, M. Hütter-Krönke et al. · Nature Medicine · 0 citations